Kewaunee Scientific Corp
KEQUKewaunee Scientific Corporation is a global provider of laboratory and healthcare furniture, equipment, and architectural services. Founded in 1906, the company specializes in designing and manufacturing custom laboratory furniture and related products for scientific, educational, and healthcare facilities. Headquartered in Statesville, North Carolina, Kewaunee serves a diverse range of clients worldwide through comprehensive project management, engineering, and installation services.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 24, 2019 | $0.19 | 2019-09-09 | 2019-09-10 |
| June 21, 2019 | $0.19 | 2019-06-06 | 2019-06-07 |
| March 25, 2019 | $0.19 | 2019-03-08 | 2019-03-11 |
| December 17, 2018 | $0.19 | 2018-12-03 | 2018-12-04 |
| September 25, 2018 | $0.19 | 2018-09-10 | 2018-09-11 |
Dividends Summary
- Consistent Payer: Kewaunee Scientific Corp has rewarded shareholders with 63 dividend payments over the past 15 years.
- Total Returned Value: Investors who held KEQU shares during this period received a total of $6.86 per share in dividend income.
- Latest Payout: The most recent dividend of $0.19/share was paid 2313 days ago, on September 24, 2019.
- Yield & Schedule: KEQU currently pays dividends quarterly with an annual yield of 1.95%.
- Dividend Growth: Since 2004, the dividend payout has grown by 171.4%, from $0.07 to $0.19.
- Dividend Reliability: KEQU has maintained or increased its dividend for 63 consecutive payments.
Company News
Discover rare investment picks for December 2023 that you might have overlooked from analysts who make less-frequent recommendations. Read more here.
Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator...
Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings. Methode Electronics posted adjusted earnings of 6 cents per share, missing market estimates of 12 cents per share. The company’s quarterly sales came in at $288.00 million versus expectations of $292.82 million, according t...
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. Ensysce Biosciences, Inc. (NASDAQ: ENSC) climbed 73.1% to settle at $...
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 44.7% to $3.9650 after the com...
